Gene · 134
Papers2,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma. | BMC Complement Med Ther | 2023 | 37990309 | PubTator, text mining | PubMed |
| The Imageable Genome. | Nat Commun | 2023 | 37957176 | PubTator, text mining | PubMed |
| Analysis of damage-associated molecular patterns in amyotrophic lateral sclerosis based on ScRNA-seq and bulk RNA-seq data. | Front Neurosci | 2023 | 37942135 | PubTator, text mining | PubMed |
| Multi-Functional Small Molecule Alleviates Fracture Pain and Promotes Bone Healing. | Adv Sci (Weinh) | 2023 | 37939302 | PubTator, text mining | PubMed |
| The effect of protocatechuic acid on neuropathic pain and possible mechanism. | Indian J Pharmacol | 2023 | 37929410 | PubTator, text mining | PubMed |
| Modulation of Neuron and Astrocyte Dopamine Receptors via Receptor-Receptor Interactions. | Pharmaceuticals (Basel) | 2023 | 37895898 | PubTator, text mining | PubMed |
| Synthesis, Computational, and Anticancer In Vitro Investigations of Aminobenzylnaphthols Derived from 2-Naphtol, Benzaldehydes, and α-Aminoacids via the Betti Reaction. | Molecules | 2023 | 37894709 | PubTator, text mining | PubMed |
| Cutaneous Manifestations of Rheumatoid Arthritis: Diagnosis and Treatment. | J Pers Med | 2023 | 37888090 | PubTator, text mining | PubMed |
| Dysregulated Cyclic Nucleotide Metabolism in Alcohol-Associated Steatohepatitis: Implications for Novel Targeted Therapies. | Biology (Basel) | 2023 | 37887031 | PubTator, text mining | PubMed |
| Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Based Synergistic Therapy for Pancreatic Cancer. | Adv Sci (Weinh) | 2023 | 37867243 | PubTator, text mining | PubMed |
| Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor. | ACS Chem Neurosci | 2023 | 37847546 | PubTator, text mining | PubMed |
| Ultrasonic-induced synthesis of novel diverse arylidenes via Knoevenagel condensation reaction. Antitumor, QSAR, docking and DFT assessment. | RSC Adv | 2023 | 37822658 | PubTator, text mining | PubMed |
| Metformin reduces the risk of developing influenza A virus related cardiovascular disease. | Heliyon | 2023 | 37810823 | PubTator, text mining | PubMed |
| Effects of gastrodin on the expression of brain aging-related genes in SAM/P-8 mice based on network pharmacology. | Ibrain | 2023 | 37786545 | PubTator, text mining | PubMed |
| Dipyridamole activates adenosine A2B receptor and AMPK/cAMP signaling and promotes myogenic differentiation of myoblastic C2C12 cells. | Front Pharmacol | 2023 | 37771723 | PubTator, text mining | PubMed |
| Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A2A and Dual A1/A2A Receptor Affinity. | Int J Mol Sci | 2023 | 37762006 | PubTator, text mining | PubMed |
| Metabolomics Applied to Pediatric Asthma: What Have We Learnt in the Past 10 Years? | Children (Basel) | 2023 | 37761413 | PubTator, text mining | PubMed |
| Chemical biology tools for protein labelling: insights into cell-cell communication. | Biochem J | 2023 | 37732646 | PubTator, text mining | PubMed |
| Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma. | Front Pharmacol | 2023 | 37724182 | PubTator, text mining | PubMed |
| Adenosine stimulates the basolateral 50 pS K+ channel in renal proximal tubule via adenosine-A1 receptor. | Front Physiol | 2023 | 37700760 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134/papers?page=8